Nephrology
Clinical
Acute kidney injury in children hospitalized with diarrheal illness in the U.S.
Diarrheal illness is the fourth leading cause of death for children younger than 5 years and the fifth leading cause of years of life lost...
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.
News
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities...
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
News
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
News
Type of renal dysfunction affects liver cirrhosis mortality risk
Patients with acute on chronic kidney disease fared the worst.
Clinical
Anticoagulant therapy for AFib in patients with end-stage renal disease
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
News
What’s new in pediatric sepsis
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.